NCT03105245

Brief Summary

This study will examine how anaesthetic technique affects ECT outcomes. Specifically, the investigators will examine how: 1) the time interval between anaesthetic and ECT stimulus, and 2) the ventilation rate before ECT stimulus, impacts on the quality of the EEG (this is a recording of brain activity during ECT and is used to judge the quality of a seizure and to guide individual patient dosing).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at below P25 for phase_3 depression

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2017

Completed
16 days until next milestone

Study Start

First participant enrolled

March 15, 2017

Completed
23 days until next milestone

First Posted

Study publicly available on registry

April 7, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2019

Completed
Last Updated

March 30, 2023

Status Verified

March 1, 2023

Enrollment Period

2 years

First QC Date

February 27, 2017

Last Update Submit

March 28, 2023

Conditions

Keywords

electroconvulsive therapyanaesthesia

Outcome Measures

Primary Outcomes (1)

  • EEG Seizure Quality Rating using the EEG Seizure Quality Rating Sheet utilised by MacPherson et al

    EEG quality will be rated manually for each ECT treatment undertaken by a participant until the conclusion of their ECT course. This rating will be done using the EEG Seizure Quality Rating Sheet utilised by MacPherson et al - low dose lignocaine added to propofol does not attenuate the response to electroconvulsive therapy; Journal of Affective Disorders, 2010; 126: 330-333

    Outcome measures will be collected immediately after each ECT treatment from the first treatment until the end of the ECT course, an estimated total of four to six weeks for most participants

Study Arms (4)

Short time interval + Normal ventilation

ACTIVE COMPARATOR
Other: Electroconvulsive Therapy (ECT) time interval + Anaesthetic (Thiopentone)

Short time interval + Hyperventilation

ACTIVE COMPARATOR
Other: Electroconvulsive Therapy (ECT) time interval + Anaesthetic (Thiopentone)

Long time interval + Normal ventilation

ACTIVE COMPARATOR
Other: Electroconvulsive Therapy (ECT) time interval + Anaesthetic (Thiopentone)

Long time interval + Hyperventilation

ACTIVE COMPARATOR
Other: Electroconvulsive Therapy (ECT) time interval + Anaesthetic (Thiopentone)

Interventions

The intervention in this study is the time interval between anaesthetic administration and ECT stimulus

Long time interval + HyperventilationLong time interval + Normal ventilationShort time interval + HyperventilationShort time interval + Normal ventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients treated with a course of ECT

You may not qualify if:

  • Use of non-standard anaesthetic agents in ECT (e.g. ketamine)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wesley Hospital Kogarah

Sydney, New South Wales, 2217, Australia

Location

MeSH Terms

Conditions

Depression

Interventions

Electroconvulsive TherapyAnestheticsThiopental

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Convulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesCentral Nervous System AgentsTherapeutic UsesThiobarbituratesBarbituratesPyrimidinonesPyrimidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Colleen Loo, MBBS

    The University of New South Wales

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Both participants and the outcome assessor (analysing EEGs) will be blinded.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Each participant will receive all four treatment conditions in randomly allocated sequence during their ECT course. That is, participants will receive either short or long anaesthetic-ECT stimulus time interval treatments, and normal or hyperventilation treatments - this results in four possible combinations, which individual participants will cycle through in random order during their ECT course (e.g. short-hyperventilation, long-normal ventilation, short-normal ventilation, long-hyperventilation).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 27, 2017

First Posted

April 7, 2017

Study Start

March 15, 2017

Primary Completion

March 15, 2019

Study Completion

March 15, 2019

Last Updated

March 30, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations